To include your compound in the COVID-19 Resource Center, submit it here.

Zaltrap improves OS in mCRC trial

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and sanofi-aventis Group (Euronext:SAN; NYSE:SNY) said Zaltrap

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE